Global stocks gain as Mexico tariffs averted, yuan falls to 2019 lows
June 10, 2019Exclusive: FCA-Renault revival may hinge on Nissan stake cut – sources
June 10, 2019Roche’s $4.3 billion Spark bid delayed again amid U.S., UK scrutiny
at
Swiss drugmaker Roche’s $4.3 billion takeover of U.S. gene therapy specialist Spark Therapeutics has been pushed back again, possibly beyond the first half, as regulators continue to scrutinize the deal for its effect on competition.
Powered by WPeMatico
